Immunocore Holdings Ltd (IMCR) support and resistance · rev $222.6M
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
This page maps Immunocore Holdings Ltd (IMCR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
IMCR currently screens at market cap $1.45B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMCR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMCR quote page for the session range and the stock page for the full model.
Not investment advice.